Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Habits Diabetes Coach/HabitNu offers a CDC-recognized digital program for diabetes prevention and self-management. The solution combines an evidence-based curriculum with personalized one-on-one coaching via mobile/web apps. Clinical results include significant weight loss, reduced HbA1c levels, improved adherence to healthy habits, and in some cases reversal of prediabetes/type 2 diabetes. Participants have shown maintained weight loss over time; average percent weight loss is reported; decreased HbA1c; some participants reversed their diabetes diagnosis. In pilot programs tracked by the CDC, participants experienced improved outcomes using this telehealth approach. The program uses the PreventT2 curriculum from the CDC with live webinars/coaching sessions plus asynchronous educational content. Clinical stage summary: Commercially deployed with real-world outcome data showing efficacy in reducing risk factors for type 2 diabetes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Habits Diabetes Coach.